Highly sensitive next-generation sequencing-based MRD testing will identify eligible patients with T-cell malignancies ...

By Karen Roman Imviva Biotech said it has FDA authorization for its Investigational Device Exemption application to use ...

Thank you for taking the first step to join the Yale SOM community. Our aim is to make the application process as straightforward as possible. Please review the information provided below, including ...